LHC Group (LHCG) Stock Rating Lowered by Zacks Investment Research
Zacks Investment Research lowered shares of LHC Group (NASDAQ:LHCG) from a buy rating to a hold rating in a research note published on Friday morning.
According to Zacks, “LHC Group provides post-acute healthcare services primarily to Medicare beneficiaries in rural markets in the southern United States. They provide home-based services through their home nursing agencies and hospices and facility-based services through their long-term acute care hospitals and outpatient rehabilitation clinics. “
LHCG has been the subject of several other research reports. Oppenheimer Holdings, Inc. raised their price objective on LHC Group from $68.00 to $80.00 and gave the company an outperform rating in a research report on Tuesday, November 7th. Royal Bank Of Canada reissued a buy rating and set a $69.00 price objective on shares of LHC Group in a research report on Tuesday, July 18th. Jefferies Group LLC raised their price objective on LHC Group from $68.00 to $83.00 and gave the company a buy rating in a research report on Tuesday, November 7th. They noted that the move was a valuation call. SunTrust Banks, Inc. reissued a buy rating and set a $75.00 price objective on shares of LHC Group in a research report on Friday, November 3rd. Finally, BidaskClub lowered LHC Group from a buy rating to a hold rating in a research report on Tuesday, July 25th. Two equities research analysts have rated the stock with a hold rating and nine have given a buy rating to the company’s stock. LHC Group currently has a consensus rating of Buy and a consensus target price of $76.40.
LHC Group (NASDAQ LHCG) opened at $67.81 on Friday. The company has a current ratio of 1.77, a quick ratio of 1.77 and a debt-to-equity ratio of 0.24. The company has a market capitalization of $1,240.00, a price-to-earnings ratio of 28.44, a price-to-earnings-growth ratio of 1.96 and a beta of 0.70. LHC Group has a 52-week low of $41.66 and a 52-week high of $76.14.
LHC Group (NASDAQ:LHCG) last announced its quarterly earnings data on Monday, November 6th. The health services provider reported $0.64 EPS for the quarter, beating the consensus estimate of $0.60 by $0.04. The business had revenue of $272.90 million during the quarter, compared to analyst estimates of $265.35 million. LHC Group had a return on equity of 9.52% and a net margin of 4.09%. The company’s revenue for the quarter was up 18.2% on a year-over-year basis. During the same quarter last year, the firm posted $0.54 earnings per share. equities research analysts forecast that LHC Group will post 2.4 EPS for the current fiscal year.
TRADEMARK VIOLATION NOTICE: “LHC Group (LHCG) Stock Rating Lowered by Zacks Investment Research” was first reported by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are reading this report on another website, it was copied illegally and reposted in violation of US & international trademark & copyright laws. The correct version of this report can be read at https://www.thecerbatgem.com/2017/11/14/lhc-group-lhcg-stock-rating-lowered-by-zacks-investment-research.html.
In other news, COO Donald Dwayne Stelly sold 2,650 shares of LHC Group stock in a transaction dated Friday, September 8th. The stock was sold at an average price of $65.34, for a total value of $173,151.00. Following the completion of the transaction, the chief operating officer now owns 109,235 shares of the company’s stock, valued at approximately $7,137,414.90. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. 14.80% of the stock is owned by insiders.
A number of hedge funds and other institutional investors have recently added to or reduced their stakes in LHCG. UBS Asset Management Americas Inc. bought a new stake in LHC Group in the 1st quarter worth about $248,000. Principal Financial Group Inc. increased its holdings in LHC Group by 3.6% in the 1st quarter. Principal Financial Group Inc. now owns 113,707 shares of the health services provider’s stock worth $6,129,000 after buying an additional 3,983 shares in the last quarter. Legal & General Group Plc increased its holdings in LHC Group by 1.2% in the 1st quarter. Legal & General Group Plc now owns 25,087 shares of the health services provider’s stock worth $1,353,000 after buying an additional 290 shares in the last quarter. Thrivent Financial For Lutherans increased its holdings in LHC Group by 4.1% in the 1st quarter. Thrivent Financial For Lutherans now owns 8,380 shares of the health services provider’s stock worth $452,000 after buying an additional 330 shares in the last quarter. Finally, Vanguard Group Inc. increased its holdings in LHC Group by 3.9% in the 1st quarter. Vanguard Group Inc. now owns 1,432,008 shares of the health services provider’s stock worth $77,185,000 after buying an additional 54,279 shares in the last quarter. Institutional investors own 87.29% of the company’s stock.
LHC Group Company Profile
LHC Group, Inc is a holding company. The Company provides post-acute healthcare services to patients through its home nursing agencies, hospice agencies, community-based services agencies and long-term acute care hospitals (LTACHs). The Company operates through four segments: home health services, hospice services, community-based services and facility-based services.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Stock Ratings for LHC Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LHC Group and related stocks with our FREE daily email newsletter.